Functional role of transporter Slc4a11 (BTR1/NaBC1) in the cornea
转运蛋白 Slc4a11 (BTR1/NaBC1) 在角膜中的功能作用
基本信息
- 批准号:8389867
- 负责人:
- 金额:$ 17.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-12-01 至 2014-11-30
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAntibodiesApoptosisAqueous HumorBicarbonatesBilateralBoratesBoronCarrier ProteinsCattleCell LineCellsClinical assessmentsConfocal MicroscopyCorneaCorneal EndotheliumCorneal StromaCorneal dystrophyCoupledDataDiffuseEdemaEndoplasmic ReticulumEndothelial CellsExhibitsFaceFamilyFuchs&apos Endothelial DystrophyFunctional disorderGenesGeneticGoalsGuidelinesHearingHereditary DiseaseHumanHydration statusImmunohistochemistryIndividualInheritedIon TransportIonsKnock-in MouseKnockout MiceKnowledgeLabelLinkLiquid substanceLocationMaintenanceMass Spectrum AnalysisMeasurementMeasuresMediatingMicroelectrodesMicroscopeMolecularMonitorMusMutationPhenotypePhysiologicalPlasmaPlayPoint MutationPositioning AttributeProcessProtein FamilyProteinsPublishingReportingRoleSymptomsSyndromeTransgenic MiceTransgenic OrganismsVisionXenopus oocytealkalinityapical membraneaqueousbasebasolateral membraneextracellularfascinatemanmembermouse modelmutantoverexpressionresearch clinical testingresearch studysolute
项目摘要
DESCRIPTION (provided by applicant): Congenital hereditary endothelial dystrophy (CHED) causes impaired vision resulting from opacification of the cornea. The recessive form of CHED (CHED2) as well as some types of Fuch's endothelial dystrophy and Harboyan syndrome were recently shown to be associated with mutations in the SLC4A11 gene that encodes BTR1/NaBC1, a member of the bicarbonate transporter family. The function and subcellular location of this protein in cornea are unknown, and there is currently no adequate animal model for the study of CHED caused by SLC4A11 mutations. The goals of the proposed experiments are to determine the molecular function of SLC4A11 and its localization in the cornea, and to generate a mouse model for CHED2. The available functional information suggests that SLC4A11 transports Na+ and borate [B(OH)4- ], although no boron transport experiments with this protein have been performed. Specific Aim 1A is to use HEK293 cells and a corneal endothelial cell line, with mass-spectrometry, to determine whether mammalian (mouse, human) SLC4A11 cotransports Na+ and boron. Specific Aim 1B is to use Xenopus oocytes, with ion-selective microelectrodes, to determine whether SLC4A11 cotransports Na+ and HCO3-. In Specific Aim 2 we will perform immunohistochemistry to determine whether Slc4a11 is located in the basolateral or apical membrane of the mouse corneal endothelium. In Specific Aim 3 we will generate and evaluate the phenotype of a mouse model of CHED2 prepared by introducing, to mouse Slc4a11, a point mutation (in the position of human R755Q) that is known to cause CHED2 in humans.
描述(由申请人提供):先天性遗传性内皮营养不良(CHED)导致角膜混浊导致视力受损。隐性形式的CHED(CHED 2)以及某些类型的Fuch内皮营养不良和Harboyan综合征最近被证明与编码BTR 1/NaBC 1的SLC 4A 11基因突变相关,BTR 1/NaBC 1是碳酸氢盐转运蛋白家族的成员。这种蛋白在角膜中的功能和亚细胞位置尚不清楚,目前还没有足够的动物模型用于研究SLC 4A 11突变引起的CHED。所提出的实验的目标是确定SLC 4A 11的分子功能及其在角膜中的定位,并产生CHED 2的小鼠模型。现有的功能信息表明,SLC 4A 11转运Na+和硼酸盐[B(OH)4- ],虽然没有硼转运实验与这种蛋白质已经进行。具体目标1A是使用HEK 293细胞和角膜内皮细胞系,用质谱法确定哺乳动物(小鼠,人)SLC 4A 11是否共转运Na+和硼。具体目标1B是使用非洲爪蟾卵母细胞,与离子选择性微电极,以确定是否SLC 4A 11共转运Na+和HCO 3-。在特定目标2中,我们将进行免疫组织化学以确定Slc 4a 11是否位于小鼠角膜内皮的基底膜或顶膜中。在特定目标3中,我们将生成并评估CHED 2小鼠模型的表型,该模型通过向小鼠Slc 4a 11引入已知在人类中引起CHED 2的点突变(在人R755 Q的位置)制备。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL L JENNINGS其他文献
MICHAEL L JENNINGS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL L JENNINGS', 18)}}的其他基金
Functional role of transporter Slc4a11 (BTR1/NaBC1) in the cornea
转运蛋白 Slc4a11 (BTR1/NaBC1) 在角膜中的功能作用
- 批准号:
8243356 - 财政年份:2011
- 资助金额:
$ 17.94万 - 项目类别:
ERYTHROCYTE POTASSIUM TRANSPORT AND VOLUME REGULATION
红细胞钾转运和容量调节
- 批准号:
2218479 - 财政年份:1995
- 资助金额:
$ 17.94万 - 项目类别:
BIOCHEMICAL STUDIES OF ERYTHROCYTE TRANSPORT PROTEINS
红细胞转运蛋白的生物化学研究
- 批准号:
2174824 - 财政年份:1987
- 资助金额:
$ 17.94万 - 项目类别:
BIOCHEMICAL STUDIES OF ERYTHROCYTE TRANSPORT PROTEINS
红细胞转运蛋白的生物化学研究
- 批准号:
2174823 - 财政年份:1987
- 资助金额:
$ 17.94万 - 项目类别:
BIOCHEMICAL STUDIES OF ERYTHROCYTE ANION EXCHANGE
红细胞阴离子交换的生物化学研究
- 批准号:
2882991 - 财政年份:1987
- 资助金额:
$ 17.94万 - 项目类别:
BIOCHEMICAL STUDIES OF ERYTHROCYTE ANION TRANSPORT
红细胞阴离子转运的生物化学研究
- 批准号:
3274301 - 财政年份:1987
- 资助金额:
$ 17.94万 - 项目类别:
BIOCHEMICAL STUDIES OF ERYTHROCYTE TRANSPORT PROTEINS
红细胞转运蛋白的生物化学研究
- 批准号:
2174825 - 财政年份:1987
- 资助金额:
$ 17.94万 - 项目类别:
ERYTHROCYTE POTASSIUM TRANSPORT AND VOLUME REGULATION
红细胞钾转运和容量调节
- 批准号:
2218478 - 财政年份:1987
- 资助金额:
$ 17.94万 - 项目类别:
BIOCHEMICAL STUDIES OF ERYTHROCYTE ANION EXCHANGE
红细胞阴离子交换的生物化学研究
- 批准号:
2634629 - 财政年份:1987
- 资助金额:
$ 17.94万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 17.94万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 17.94万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 17.94万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 17.94万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 17.94万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 17.94万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 17.94万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 17.94万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 17.94万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 17.94万 - 项目类别:














{{item.name}}会员




